One of UK’s largest hemp farms forced to destroy crop amid policy changes
(Photo courtesy of Hempen) The case of Hempen, the United Kingdom’s not-for-profit farming cooperative, illustrates the extra hurdles British hemp farmers face in not being able to use the flower, the most valuable part of their crop. Based in Oxfordshire, Hempen had been growing hemp since 2015. And, until... Read more
Canopy breaks ground on hemp industrial park in New York
One of the largest cannabis companies in the world made a significant move into the U.S. hemp industry Monday by breaking ground on a new industrial park for hemp processing in New York. Canadian cannabis giant Canopy Growth Corp., based in Smiths Falls, Ontario, unveiled plans for a $150... Read more
Michigan hemp farmers worry privacy law could hurt business
Some in Michigan’s fledgling hemp industry are concerned that a state privacy law preventing agriculture officials from disclosing hemp farmers’ identities and locations could negatively affect their businesses. As a stipulation under the 2018 Farm Bill, applicants who seek to produce and process hemp must give their GPS coordinates.... Read more
Curaleaf scrubs website for medical claims following FDA warning
After federal regulators warned cannabis giant Curaleaf last week against making unsubstantiated medical claims for its CBD products, the company has taken action. The Massachusetts cannabis company removed its blog and deleted social media posts and articles on its website saying its products can be used to treat medical conditions... Read more
SOL Global increases ownership stake in HeavenlyRx
Cannabis investment company SOL Global Investments purchased additional common shares to raise its ownership in its CBD-focused wellness subsidiary HeavenlyRx to 44.53%. As part of a larger private offering, the Toronto-based international investment company announced Monday it spent an additional $18.1 million (23.9 million Canadian dollars) on HeavenlyRx. The... Read more
European Medicines Agency panel OKs GW Pharma’s cannabis drug
The Committee for Medicinal Products for Human Use (CHMP) recommended approval of the British company’s cannabis-based medicine Epidiolex, said the drug’s maker, GW Pharmaceuticals. The CHMP is tasked with preparing the European Medicines Agency’s opinions on queries about the marketing of human medicines. The CHMP opinion was adopted July... Read more
‘Imperative to have mainstream experience’ in the growing CBD sector: Q&A with HeavenlyRx CEO Paul Norman
Paul Norman As hemp and CBD companies increasingly lure executive-level talent away from mainstream corporations, many are coming from large food companies. The Kellogg Co. is one of them. The $13 billion food giant recently saw three of its executives leave for positions in the cannabis space, including Paul... Read more
North Carolina lawmakers vote to delay smokable hemp ban
Another set of policymakers in North Carolina has signed off on banning smokable hemp until December 2020 in hopes that tests will be developed by then to distinguish the plant from marijuana. The state House Judiciary Committee voted to approve the original measure passed by the Senate, which would... Read more
South Carolina law enforcement cracks down on smokable hemp
In the latest blow dealt to the burgeoning smokable hemp flower market in the Southeast United States, South Carolina law enforcement officials are requiring retailers across the state to pull raw, unprocessed hemp products from their store shelves. The action comes after an opinion handed down from the State... Read more
Canadian CBD maker sponsors athlete research with UFC
Canadian marijuana giant Aurora Cannabis is sponsoring CBD research with the UFC to determine if the cannabinoid treatments are effective in treating pain and inflammation. The partnership marks a milestone for the cannabis industry, where individual athletes commonly strike sponsorship deals but few prominent leagues agree to research for... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )